Join
Live feed
·
INSIDERFilingvia Quantisnow
TherapeuticsMD Inc. logo

Chief Executive Officer Walker Marlan D converted options into 8,281 shares, increasing direct ownership by 13% to 70,846 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TXMD· TherapeuticsMD Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TXMD (TherapeuticsMD Inc.) and more on Quantisnow.